Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
November-2021 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
November-2021 Volume 22 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells in vitro

  • Authors:
    • Xin Chen
    • Pengli Xu
    • Huijun Zhang
    • Xiaosan Su
    • Lihua Guo
    • Xuhong Zhou
    • Junliang Wang
    • Peng Huang
    • Qingzhi Zhang
    • Ruifen Sun
  • View Affiliations / Copyright

    Affiliations: Molecular Biology Laboratory, Yunnan University of Chinese Medicine, Kunming, Yunnan 650500, P.R. China, Collaborative Innovation Center, Henan University of Chinese Medicine, Zhengzhou, Henan 450000, P.R. China, Department of Cardiothoracic Surgery, Huashan Hospital of Fudan University, Shanghai 200030, P.R. China, Research and Experiment Center, Yunnan University of Chinese Traditional Medicine, Kunming, Yunnan 650500, P.R. China, Department of Oncology, Yunnan Provincial Hospital of Chinese Medicine, Kunming, Yunnan 650500, P.R. China, Department of Urology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Tokyo 163‑8001, Japan
    Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 754
    |
    Published online on: August 31, 2021
       https://doi.org/10.3892/ol.2021.13015
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

In the present study, due to the complex and numerous targets of Sarcandrae Herb (also known as Zhong Jie Feng), network pharmacology was performed to analyze its therapeutic effect on 2 cervical cancer cell lines, which could assist with the development of novel therapies. The results suggested that the natural flavonoid quercetin (Que), the effective antitumor ingredient in SH, which is widely present in a variety of plants, may depend on the target, EGFR. Previous studies have shown that EGFR serves a crucial role in the occurrence and development of cervical cancer, but its downstream molecules and regulatory mechanisms remain unknown. The anti‑cervical cancer cell properties of Que, which are present in ubiquitous plants, were examined in vitro to identify the association between Que and its underlying pathway using MTT assays, flow cytometry, western blot analysis and Transwell assays. It was found that Que reduced cervical cancer cell viability, promoted G2/M phase cell cycle arrest and cell apoptosis, as well as inhibited cell migration and invasion. The Tyr1068 phosphorylation site of EGFR and the corresponding ERK target were also examined and the 2 kinases were markedly activated by Que. Furthermore, the EGFR inhibitor, afatinib and the ERK inhibitor, U0126 blocked the increase of EGFR and ERK phosphorylation, and resulted in a notable enhancement of apoptosis and cell cycle arrest. Therefore, to the best of our knowledge, the current results provided the first evidence that EGFR and ERK activation induced by Que could resist Que‑induced anticancer activities. On this basis, the present study determined the role of EGFR and the underlying signaling pathways involved in the anti‑cervical cancer malignant behavior induced by Que and identified the negative regulatory association.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

View References

1 

Woo S, Atun R, Ward ZJ, Scott AM, Hricak H and Vargas HA: Diagnostic performance of conventional and advanced imaging modalities for assessing newly diagnosed cervical cancer: Systematic review and meta-analysis. Eur Radiol. 30:5560–5577. 2020. View Article : Google Scholar : PubMed/NCBI

2 

Tran KN, Park Y, Kim BW, Oh JK and Ki M: Incidence and mortality of cervical cancer in Vietnam and Korea (1999–2017). Epidemiol Health. 42:e20200752020. View Article : Google Scholar : PubMed/NCBI

3 

Benitez-Restrepo CC, Arias-Ortiz NE and Arboleda-Ruiz WA: Cervical cancer incidence and patient survival in Manizales, Colombia, 2008–2012. Rev Peru Med Exp Salud Publica. 37:438–445. 2020.(In Spanish, English). View Article : Google Scholar : PubMed/NCBI

4 

D'Alton P, Craddock F, Bergin N and Lynch J: Exploring the lived experience of partners of women impacted by cervical cancer and the CervicalCheck screening failure in Ireland. Psychooncology. Jun 7–2021.(Epub ahead of print). View Article : Google Scholar

5 

Malikova H, Burghardtova M, Fejfarova K, Nadova K and Weichet J: Advanced cervical cancer in young women: Imaging study of late and very late radiation-related side effects after successful treatment by combined radiotherapy. Quant Imaging Med Surg. 11:21–31. 2021. View Article : Google Scholar : PubMed/NCBI

6 

Zhang FY, Li JJ, Zhou Y and Xu XY: Review for sedative and hypnotic mechanism of sedative traditional Chinese medicine and relative active components on neurotransmitters. Zhongguo Zhongyao Zazhi. 41:4320–4327. 2016.(In Chinese). PubMed/NCBI

7 

Qian C, Kuang M and Wang Y: Effect of qianghuo erhuang decoction on T regulatory and T Helper 17 cells in treatment of adjuvant-induced arthritis in rats. Sci Rep. 7:171982017. View Article : Google Scholar : PubMed/NCBI

8 

Chen H, Feng X, Gao L, Mickymaray S, Paramasivam A, Abdulaziz Alfaiz F, Almasmoum HA, Ghaith MM, Almaimani RA and Aziz Ibrahim IA: Inhibiting the PI3K/AKT/mTOR signalling pathway with copper oxide nanoparticles from Houttuynia cordata plant: Attenuating the proliferation of cervical cancer cells. Artif Cells Nanomed Biotechnol. 49:240–249. 2021. View Article : Google Scholar : PubMed/NCBI

9 

Zeng Y, Liu J, Zhang Q, Qin X, Li Z, Sun G and Jin S: The traditional uses, phytochemistry and pharmacology of Sarcandra glabra (Thunb.) Nakai, a Chinese herb with potential for development: Review. Front Pharmacol. 12:6529262021.Review. View Article : Google Scholar : PubMed/NCBI

10 

Zhang Y, Yuan T, Li Y, Wu N and Dai X: Network pharmacology analysis of the mechanisms of compound Herba Sarcandrae (Fufang Zhongjiefeng) aerosol in chronic pharyngitis treatment. Drug Des Devel Ther. 15:2783–2803. 2021. View Article : Google Scholar : PubMed/NCBI

11 

Guo X, Shen L, Tong Y, Zhang J, Wu G, He Q, Yu S, Ye X, Zou L, Zhang Z, et al: Antitumor activity of caffeic acid 3,4-dihydroxyphenethyl ester and its pharmacokinetic and metabolic properties. Phytomedicine. 20:904–912. 2013. View Article : Google Scholar : PubMed/NCBI

12 

Trusov NV, Apryatin SA, Shipelin VA and Gmoshinski IV: Full transcriptome analysis of gene expression in liver of mice in a comparative study of quercetin efficiency on two obesity models. Probl Endokrinol (Mosk). 66:31–47. 2020.(In Russian). View Article : Google Scholar : PubMed/NCBI

13 

Flater D: A system of quantities from software metrology. Measurement (Lond). 168:2021.doi: 10.1016/j.measurement.2020.108435. PubMed/NCBI

14 

Mokhtari Sangdehi SR, Hajizadeh Moghaddam A and Ranjbar M: Anti-apoptotic effect of silymarin-loaded chitosan nanoparticles on hippocampal caspase-3 and Bcl-2 expression following cerebral ischemia/reperfusion injury. Int J Neurosci. Jan 21–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

15 

Zhang X, Huang R, Gopalakrishnan S, Cao-Milán R and Rotello VM: Bioorthogonal nanozymes: Progress towards therapeutic applications. Trends Chem. 1:90–98. 2019. View Article : Google Scholar : PubMed/NCBI

16 

Luckett R and Feldman S: Will HPV vaccination affect cervical cancer morbidity and mortality world-wide? Hum Vaccin Immunother. 12:1373–1374. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Dehelean CA, Marcovici I, Soica C, Mioc M, Coricovac D, Iurciuc S, Cretu OM and Pinzaru I: Plant-derived anticancer compounds as new perspectives in drug discovery and alternative therapy. Molecules. 26:262021. View Article : Google Scholar

18 

Mohsenpour H, Pesce M, Patruno A, Bahrami A, Pour PM and Farzaei MH: A review of plant extracts and plant-derived natural compounds in the prevention/treatment of neonatal hypoxic-ischemic brain injury. Int J Mol Sci. 22:222021. View Article : Google Scholar

19 

Yoo S, Yang HC, Lee S, Shin J, Min S, Lee E, Song M and Lee D: A deep learning-based approach for identifying the medicinal uses of plant-derived natural compounds. Front Pharmacol. 11:5848752020. View Article : Google Scholar : PubMed/NCBI

20 

Vu DL, Žabčíková S, Červenka L, Ertek B and Dilgin Y: Sensitive voltammetric determination of natural flavonoid quercetin on a disposable graphite lead. Food Technol Biotechnol. 53:379–384. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Harwood M, Danielewska-Nikiel B, Borzelleca JF, Flamm GW, Williams GM and Lines TC: A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 45:2179–2205. 2007. View Article : Google Scholar : PubMed/NCBI

22 

Elmowafy M, Musa A, Alnusaire TS, et al: Olive Oil/Pluronic Oleogels for Skin Delivery of Quercetin: In Vitro Characterization and Ex Vivo Skin Permeability. Polymers (Basel). 13:2021. View Article : Google Scholar : PubMed/NCBI

23 

Kim JM, Seo SW, Han DG, Yun H and Yoon IS: Assessment of metabolic interaction between repaglinide and quercetin via mixed inhibition in the liver: In vitro and in vivo. Pharmaceutics. May 23–2021.(Epub ahead of print).

24 

Boulton DW, Walle UK and Walle T: Fate of the flavonoid quercetin in human cell lines: Chemical instability and metabolism. J Pharm Pharmacol. 51:353–359. 1999. View Article : Google Scholar : PubMed/NCBI

25 

Ferry DR, Smith A, Malkhandi J, Fyfe DW, deTakats PG, Anderson D, Baker J and Kerr DJ: Phase I clinical trial of the flavonoid quercetin: Pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res. 2:659–668. 1996.PubMed/NCBI

26 

Chalet C, Hollebrands B, Duchateau GS and Augustijns P: Intestinal phase-II metabolism of quercetin in HT29 cells, 3D human intestinal tissues and in healthy volunteers: A qualitative comparison using LC-IMS-MS and LC-HRMS. Xenobiotica. 49:945–952. 2019. View Article : Google Scholar : PubMed/NCBI

27 

Rashedi J, Ghorbanihaghjo A, Asgharzadeh M and Baradaran B: Chitosan and quercetin: Potential hand in hand encountering tumors in oral delivery system. Curr Pharm Des. 25:3074–3086. 2019. View Article : Google Scholar : PubMed/NCBI

28 

Peng Z, Wang Q, Zhang Y, He J and Zheng J: EBP50 interacts with EGFR and regulates EGFR signaling to affect the prognosis of cervical cancer patients. Int J Oncol. 49:1737–1745. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Zhang W, Gao Y, Jiang Y, Ping L, Cheng H and Zhang J: EGFR promoter methylation detection in cervical cancer by a hybridization-fluorescence polarization assay. Diagn Mol Pathol. 22:102–106. 2013. View Article : Google Scholar : PubMed/NCBI

30 

Hartman Z, Geldenhuys WJ and Agazie YM: A specific amino acid context in EGFR and HER2 phosphorylation sites enables selective binding to the active site of Src homology phosphatase 2 (SHP2). J Biol Chem. 295:3563–3575. 2020. View Article : Google Scholar : PubMed/NCBI

31 

Guerrero C, Pesce L, Lecuona E, Ridge KM and Sznajder JI: Dopamine activates ERKs in alveolar epithelial cells via Ras-PKC-dependent and Grb2/Sos-independent mechanisms. Am J Physiol Lung Cell Mol Physiol. 282:L1099–L1107. 2002. View Article : Google Scholar : PubMed/NCBI

32 

Liu Y, Shi QF, Ye YC, Tashiro S, Onodera S and Ikejima T: Activated O2(•-) and H2O2 mediated cell survival in SU11274-treated non-small-cell lung cancer A549 cells via c-Met-PI3K-Akt and c-Met-Grb2/SOS-Ras-p38 pathways. J Pharmacol Sci. 119:150–159. 2012. View Article : Google Scholar : PubMed/NCBI

33 

Viñas JL, Spence M, Porter CJ, Douvris A, Gutsol A, Zimpelmann JA, Campbell PA and Burns KD: micro-RNA-486-5p protects against kidney ischemic injury and modifies the apoptotic transcriptome in proximal tubules. Kidney Int. Jun 26–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI

34 

Xu Z, Shi X, Bao M, Song X, Zhang Y, Wang H, Xie H, Mao F, Wang S, Jin H, et al: Transcriptome-wide analysis of RNA m6A methylation and gene expression changes among two arabidopsis ecotypes and their reciprocal hybrids. Front Plant Sci. 12:6851892021. View Article : Google Scholar : PubMed/NCBI

35 

Toki MI, Carvajal-Hausdorf DE, Altan M, McLaughlin J, Henick B, Schalper KA, Syrigos KN and Rimm DL: EGFR-GRB2 protein colocalization is a prognostic factor unrelated to overall EGFR expression or EGFR mutation in lung adenocarcinoma. J Thorac Oncol. 11:1901–1911. 2016. View Article : Google Scholar : PubMed/NCBI

36 

Ouyang L, Chen Y, Wang XY, Lu RF, Zhang SY, Tian M, Xie T, Liu B and He G: Polygonatum odoratum lectin induces apoptosis and autophagy via targeting EGFR-mediated Ras-Raf-MEK-ERK pathway in human MCF-7 breast cancer cells. Phytomedicine. 21:1658–1665. 2014. View Article : Google Scholar : PubMed/NCBI

37 

Correia I, Wilson D, Hube B and Pla J: Characterization of a Candida albicans mutant defective in all MAPKs highlights the major role of Hog1 in the MAPK signaling network. J Fungi (Basel). 6:62020.

38 

Dalton GD and Howlett AC: Cannabinoid CB1 receptors transactivate multiple receptor tyrosine kinases and regulate serine/threonine kinases to activate ERK in neuronal cells. Br J Pharmacol. 165:2497–2511. 2012. View Article : Google Scholar : PubMed/NCBI

39 

Tsarouhas V, Yao L and Samakovlis C: Src kinases and ERK activate distinct responses to Stitcher receptor tyrosine kinase signaling during wound healing in Drosophila. J Cell Sci. 127:1829–1839. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Qi ZH, Xu HX, Zhang SR, Xu JZ, Li S, Gao HL, Jin W, Wang WQ, Wu CT, Ni QX, et al: RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling. Int J Oncol. 52:1105–1116. 2018.PubMed/NCBI

41 

Yu X, Stallone JN, Heaps CL and Han G: The activation of G protein-coupled estrogen receptor induces relaxation via cAMP as well as potentiates contraction via EGFR transactivation in porcine coronary arteries. PLoS One. 13:e01914182018. View Article : Google Scholar : PubMed/NCBI

42 

Mulner-Lorillon O, Chassé H, Morales J, Bellé R and Cormier P: MAPK/ERK activity is required for the successful progression of mitosis in sea urchin embryos. Dev Biol. 421:194–203. 2017. View Article : Google Scholar : PubMed/NCBI

43 

Deng XH, Song HY, Zhou YF, Yuan GY and Zheng FJ: Effects of quercetin on the proliferation of breast cancer cells and expression of survivin in vitro. Exp Ther Med. 6:1155–1158. 2013. View Article : Google Scholar : PubMed/NCBI

44 

Kim SH, Yoo ES, Woo JS, Han SH, Lee JH, Jung SH, Kim HJ and Jung JY: Antitumor and apoptotic effects of quercetin on human melanoma cells involving JNK/P38 MAPK signaling activation. Eur J Pharmacol. 860:1725682019. View Article : Google Scholar : PubMed/NCBI

45 

Balakrishnan S, Mukherjee S, Das S, Bhat FA, Raja Singh P, Patra CR and Arunakaran J: Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231). Cell Biochem Funct. 35:217–231. 2017. View Article : Google Scholar : PubMed/NCBI

46 

Mina U, Smiti K and Yadav P: Thermotolerant wheat cultivar (Triticum aestivum L. var. WR544) response to ozone, EDU, and particulate matter interactive exposure. Environ Monit Assess. 193:3182021. View Article : Google Scholar : PubMed/NCBI

47 

Troth EV and Kyle DE: EdU incorporation to assess cell proliferation and drug susceptibility in Naegleria fowleri. Antimicrob Agents Chemother. 65:e00017212021. View Article : Google Scholar : PubMed/NCBI

48 

Wu LW, Chiang YM, Chuang HC, Lo CP, Yang KY, Wang SY and Shyur LF: A novel polyacetylene significantly inhibits angiogenesis and promotes apoptosis in human endothelial cells through activation of the CDK inhibitors and caspase-7. Planta Med. 73:655–661. 2007. View Article : Google Scholar : PubMed/NCBI

49 

Xu P, Cai X, Zhang W, Li Y, Qiu P, Lu D and He X: Flavonoids of Rosa roxburghii Tratt exhibit radioprotection and anti-apoptosis properties via the Bcl-2(Ca(2+))/Caspase-3/PARP-1 pathway. Apoptosis. 21:1125–1143. 2016. View Article : Google Scholar : PubMed/NCBI

50 

Napso T and Fares F: Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells. Int J Oncol. 44:1971–1979. 2014. View Article : Google Scholar : PubMed/NCBI

51 

Ikehata M, Yamada A, Fujita K, Yoshida Y, Kato T, Sakashita A, Ogata H, Iijima T, Kuroda M, Chikazu D, et al: Cooperation of Rho family proteins Rac1 and Cdc42 in cartilage development and calcified tissue formation. Biochem Biophys Res Commun. 500:525–529. 2018. View Article : Google Scholar : PubMed/NCBI

52 

Sha JY, Li JH, Zhou YD, Yang JY, Liu W, Jiang S, Wang YP, Zhang R, Di P and Li W: The p53/p21/p16 and PI3K/Akt signaling pathways are involved in the ameliorative effects of maltol on D-galactose-induced liver and kidney aging and injury. Phytother Res ptr. 71422021.PubMed/NCBI

53 

Costa BP, Nassr MT, Diz FM, Fernandes KHA, Antunes GL, Grun LK, Barbé-Tuana FM, Nunes FB, Branchini G and de Oliveira JR: Methoxyeugenol regulates the p53/p21 pathway and suppresses human endometrial cancer cell proliferation. J Ethnopharmacol. 267:1136452021. View Article : Google Scholar : PubMed/NCBI

54 

Zeng R: Expression of p53, p21, PCNA and COX-2 and its relationship with recurrence in the early-stage laryngeal cancer with negative surgical margin. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 30:349–352. 3562016.(In Chinese). PubMed/NCBI

55 

Chiappara G, Gjomarkaj M, Sciarrino S, Vitulo P, Pipitone L and Pace E: Altered expression of p21, activated caspase-3, and PCNA in bronchiolar epithelium of smokers with and without chronic obstructive pulmonary disease. Exp Lung Res. 40:343–353. 2014. View Article : Google Scholar : PubMed/NCBI

56 

Li P, Liu X, Hao Z, Jia Y, Zhao X, Xie D, Dong J and Zeng F: Dual Repressive Function by Cip1, a Budding Yeast Analog of p21, in Cell-Cycle START Regulation. Front Microbiol. 11:16232020. View Article : Google Scholar : PubMed/NCBI

57 

Avkiran M and Marber MS: Feeling the stress: MAPKKK-MAPKK-MAPK signaling cascades in heart failure. J Mol Cell Cardiol. 48:283–285. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Chen X, Xu P, Zhang H, Su X, Guo L, Zhou X, Wang J, Huang P, Zhang Q, Sun R, Sun R, et al: EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>. Oncol Lett 22: 754, 2021.
APA
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X. ... Sun, R. (2021). EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>. Oncology Letters, 22, 754. https://doi.org/10.3892/ol.2021.13015
MLA
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X., Wang, J., Huang, P., Zhang, Q., Sun, R."EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>". Oncology Letters 22.5 (2021): 754.
Chicago
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X., Wang, J., Huang, P., Zhang, Q., Sun, R."EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>". Oncology Letters 22, no. 5 (2021): 754. https://doi.org/10.3892/ol.2021.13015
Copy and paste a formatted citation
x
Spandidos Publications style
Chen X, Xu P, Zhang H, Su X, Guo L, Zhou X, Wang J, Huang P, Zhang Q, Sun R, Sun R, et al: EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>. Oncol Lett 22: 754, 2021.
APA
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X. ... Sun, R. (2021). EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>. Oncology Letters, 22, 754. https://doi.org/10.3892/ol.2021.13015
MLA
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X., Wang, J., Huang, P., Zhang, Q., Sun, R."EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>". Oncology Letters 22.5 (2021): 754.
Chicago
Chen, X., Xu, P., Zhang, H., Su, X., Guo, L., Zhou, X., Wang, J., Huang, P., Zhang, Q., Sun, R."EGFR and ERK activation resists flavonoid quercetin‑induced anticancer activities in human cervical cancer cells <em>in vitro</em>". Oncology Letters 22, no. 5 (2021): 754. https://doi.org/10.3892/ol.2021.13015
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team